| Literature DB >> 35292825 |
Adrián Sánchez-Visedo1, Francisco Javier Ferrero2, José M Costa-Fernández3, María T Fernández-Argüelles3.
Abstract
Nucleic acid enzymes (NAzymes) are a class of nucleic acid molecules with catalytic activity, which can be modulated by the presence of different species such as metal ions, genetic biomarkers, small molecules or proteins, among others. NAzymes offer several important advantages for development of novel bioanalytical strategies, resulting from their functionality as specific recognition elements and as amplified analytical signal generators, making them ideal candidates for developing highly specific bioanalytical strategies for the detection of a wide variety of targets. When coupled with the exceptional features of inorganic nanoparticles (NPs), the sensitivity of the assays can be significantly improved, allowing the detection of targets using many different detection techniques including visual readout, spectrophotometry, fluorimetry, electrochemiluminescence, voltammetry, and single-particle inductively coupled plasma-mass spectrometry. Here we provide an overview of the fundamentals of novel strategies developed to achieve analytical signal amplification based on the use of NAzymes coupled with inorganic NPs. Some representative examples of such strategies for the highly sensitive detection of different targets will be presented, including metal ions, proteins, DNA- or RNA-based biomarkers, and small molecules or microorganisms. Furthermore, future prospective challenges will be discussed.Entities:
Keywords: Analytical signal amplification; DNAzymes; MNAzymes; Nanoparticles; Nucleic acid enzymes
Mesh:
Substances:
Year: 2022 PMID: 35292825 PMCID: PMC8923336 DOI: 10.1007/s00216-022-03998-5
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Fig. 1Scheme of RNA-cleaving NAzyme conformations. Left: A DNAzyme with cleaving capability is represented in green. When a substrate containing two RNA bases (in blue) hybridizes with the DNAzyme, the cleavage takes place, generating two shorter sequences that are easily displaced. Hence, a new substrate molecule can bind the DNAzyme to start the process again. P1 and P2 are two probes located at both ends (nanoparticles [NPs], dyes, fluorophores, etc.). Changes in the distance between them will serve to monitor the presence of substrate. Right: An MNAzyme is represented in green. The catalytic core has been divided into two parts, and another sequence (complementary to the target sequence) was introduced at the bottom. The behavior is similar to the DNAzyme on the left, but the presence of a target is needed to activate the catalytic activity of the MNAzyme
Summary of some characteristics of NAzymes applications
| Method | Target | Detection | Sample | Time, temperature | LOD | Linear range | Ref. |
|---|---|---|---|---|---|---|---|
DNAzymes AuNPs | Pb2+ | SPR | Clinical human serum | 20 min 25 °C | 8.56 pM | 10−11 M to 10−6 M | [ |
| Groundwater | 25 min 37 °C | 80 pM | 10−11 M to 10−6 M | [ | |||
| LFT | Soil | 15 min 25 °C | 0.05 nM | 0.01 to 100 μM | [ | ||
| UO22+ | RLS | Water | 10 min 25 °C | 4.09 nM | 1.36 10−8 to 1.50 10−7 M | [ | |
| WMS | Water | 10 min 25 °C 20 min 55 °C | 2.87 nM | 9.57 to 120 nM | [ | ||
| Colorimetric sensor | Drinking water | 30 min 25 °C | 50 nM | 50 to 500 nM | [ | ||
| Hg2+ | Fluorescence sensor | Chinese herbs | 85 min 25 °C | 80 pM | 0.2 to 150 nM | [ | |
| Zn2+ Cu2+ | Fluorescence cell imaging | HepG2 Cells | 180 min 37 °C | 0.47 nM Zn2+ 0.45 nM Cu2+ | 1 nM to 30 nM Zn2+, 1 nM to 20 nM Cu2+ | [ | |
| miRNA-141 | LOVE-1cells, SMMC-7721 cells, HeLa cells, 22Rv1 cells | 8 h 37 °C | 25 pM | – | [ | ||
| Zn2+ | Hela cells | 60 min 37 °C | – | 1 to 10 μM | [ | ||
| DENV-2 NGC | Colorimetric sensor | Mosquito cells | 30 min 37 °C | 10 TCID50 | 10 to 106 TCID50 units | [ | |
DNAzymes (G-quadruplex) AuNPs | Thrombin | Colorimetric sensor | Not applied to real samples | 90 min 4 °C | 0.6 nM | 0.8 to 10 nM | [ |
| Myoglobin | Serum | 180 min 37 °C 5 min 25 °C | 2.5 nM | 2.5 to 100 nM | [ | ||
| Water | 5 min 95 °C 60 min 37 °C 205 min 25 °C | 0.44 nM | 0.5 to 50 nM | [ | |||
| SEB | Human serum | 5 min 95 °C 85 min 25 °C | 1 pg mL−1 | 0.1 to 500 pg mL−1 | [ | ||
| CEA | Electrochemical (impedance) | Human serum | 160 min 25 °C | 0.42 pg mL−1 | 1.0 pg mL−1 to 20 ng mL−1 | [ | |
| miR-26a | Not applied to real samples | 120 min 25 °C | 1.5 10−17 M | 3.0 10−17 M to 1.0 10−14 M | [ | ||
| Thrombin | DPV | Human blood serum | 100 min 4 °C | 20 fM | 100 fM to 20 nM | [ | |
| CA19-9 | CE-CLIA | Human serum | 60 min 37 °C | 0.016 U mL−1 | 0.025 to 1.00 U mL−1 | [ | |
DNAzymes RGO-AuNPs | Pb2+ | DPV | River, lake, and tap water | 45 min 37 °C | 15 pM | 0.05 nM to 0.4 mM | [ |
DNAzymes PtNPs/TiO2/α-Fe2O3 | Drinking water, serum | 40 min 37 °C 180 min 25 °C | 0.29 pM | 1 pM to 0.1 μM | [ | ||
DNAzymes (G-quadruplex) AuNPs/GQDs | CEA | Human serum | 90 min 25 °C | 3.2 fg mL−1 | 10 fg mL−1 to 200 ng mL−1 | [ | |
DNAzymes AuNPs CdSeTe@ZnSNPs | Thrombin | ECL | Human serum | 6 h 37 °C | 0.28 fM | 1 fM to 1 nM | [ |
DNAzymes (G-quadruplex) AgNPs | Cardiac troponin T | Chemiluminescence | Human serum | 60 min 37 °C | 84 fg L−1 | 0.003 to 270 ng L−1 | [ |
DNAzymes PtNPs/CNTs | DNA | Chronoamperometry | Not applied to real samples | 20 h 25 °C | 0.6 fM | 1.0 fM to 10 pM | [ |
DNAzymes (G-quadruplex) Au@AgNPs | Hg2+ | SWV | River, lake, and drinking water | 70 min 25 °C | 0.006 μg L−1 | 0.002 to 20 μg L−1 | [ |
DNAzymes ZrNPs | GHK peptide | Serum | 80 min 37 °C 30 min 25 °C | 0.2 pg mL−1 | 1 pg mL−1 to 1 ng mL−1 | [ | |
DNAzymes (G-quadruplex) MNPs | Thrombin | Optical sensor | Human plasma | 90 min 37 °C | 0.5 nM | 0.5 to 20 nM | [ |
| MUC1 | Colorimetric sensor | Serum | 150 min 25 °C | 5.08 nM | 50 to 1000 nM | [ | |
| Cocaine, cocaine metabolite | Serum, plasma, urine | 120 min 25 °C | 50 nM | 0.1 μM to 20 μM | [ | ||
MNAzymes AuNPs | Gon, Syph, Mal, HBV | Colorimetric sensor | Not applied to real samples | 80 min 50 °C | 50 pM | 50 to 1000 pM | [ |
| Blood | 165 min 50 °C | 102 CFU mL−1 | 107 to 100 CFU mL−1 | [ | |||
| SARS-CoV-2 | Blood | 80 min 50 °C | 103 copies of DNA/reaction | 1011 to 100 copies of DNA/reaction | [ | ||
| ATP | Human serum | 90 min 25 °C | 5.3 pM | 10 pM to 100 nM | [ | ||
| Malaria DNA, miRNA-10b | sp-ICP-MS | Serum | 3 h 45 °C 15 min 60 °C | 0.1 pmol L−1 | 0.1 to 25 pmol L−1 | [ | |
| miR-21, miR-141, let-7d, miR-200b, miR-429 | Fluorescence cell imaging | HeLa cells | 40 h 37 °C | 10 pM | – | [ | |
MNAzymes MNPs | miRNA | Optomagnetic measurement | HeLa cells | 60 min 50 °C | 1.5 pM | 10 pM to 100 nM | [ |
| mRNA | Cell imaging | MCF-7 cells | 30 h 37 °C | 18 pM | – | [ | |
MNAzymes MBeads | miRNA-21, miRNA-155, miRNA-10b | ICP-MS | Human serum, HepG-2 cells | 3 h 37 °C | 11 pmol L−1 | 50 to 2000 pmol L−1 | [ |
| DNA | Fluorescence | Not applied to real samples | 60 min 25 °C | 180 fM | 7.8 to 31.2 pM | [ | |
MNAzymes CuMn-CeO2 NPs | GBS | Electro-chemiluminescence | Serum | 120 min 37 °C | 68 aM | 0.1 fM to 1 nM | [ |
SPR surface plasmon resonance, LTF lateral flow test, RLS resonance light scattering, WMS wireless magnetoelastic sensor, DPV differential pulse voltammetry, CE-CLIA capillary electrophoresis-based chemiluminescent immunoassay, ECL electro-chemiluminescence, SWV square wave voltammetry, ICP-MS inductively coupled plasma, sp-ICP-MS single-particle ICP-MS, DENV-2 NGC dengue virus, SEB staphylococcal enterotoxin B, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen, GHK glycyl-l-histidyl-l-lysine, Gon gonorrhea, Syph syphilis bacteria, Mal malaria parasite, HBV hepatitis B virus, ATP adenosine triphosphate, GBS group B streptococci
Fig. 2Scheme of the Au/Ag core/shell NPs, surface-modified with the hemin/G-quadruplex DNAzyme and the DNA (green arrow) complementary to the sequence immobilized onto the electrode surface (purple arrow). The presence of Hg2+ generates the double-stranded DNA, bringing the NPs and the DNAzyme close to the surface of the electrode where the catalyzed oxidation of H2O2 is measured [39]. This figure is licensed under a CC BY 4.0 license and can be found at https://creativecommons.org/licenses/by/4.0/. It is attributed to Yanling Zhao and Xianmei Xie, and the original version can be found at 10.21577/0103-5053.20170133
Fig. 3Scheme of the simultaneous imaging of Zn2+ and Cu2+ in living cells based on DNAzyme-modified AuNPs [21]. Reprinted with permission from Analytical Chemistry 2015 87 (9), 4829–4835, Copyright © 2015 American Chemical Society
Fig. 4Schematic illustration of the dual signal amplification strategy-based electro-chemiluminescence (ECL) aptasensor for detection of thrombin [36]. In the upper part of the figure, a hairpin DNA containing a thrombin aptamer and a DNAzyme is shown. The presence of thrombin opens the hairpin, so the substrate binds to the DNAzyme, that in the presence of Zn ions cleaves the substrate, which is liberated, and the DNAzyme is available to bind a new substrate sequence (first amplification step). In the lower part of the figure, a capture DNA probe is immobilized onto the surface of a gold electrode. The presence of the cleaved substrate opens the capture DNA that can now interact with the biobar-coded AuNPs-CdSeTe@ZnS QDs. Each AuNP contains many CdSeTe@ZnS QDs, which are the ECL signal probes that constitute the second amplification step. Reprinted with permission from ACS Appl. Mater. Interfaces 2015, 7, 1, 696–703, Copyright © 2014 American Chemical Society
Fig. 5MNAzymes coupled with NPs as a signal amplification tool. a AuNPs as probes used in MNAzyme aggregation assays with visual/UV-Vis and sp-ICP-MS detection [44–48]. b AuNPs as probes used as quenchers of organic fluorophores (F) coupled to MNAzymes for fluorescence detection [49]. c MNPs as probes used in MNAzyme aggregation assays with optomagnetic detection [50]. d MNP probes used as carriers for multiple lanthanide (L) detection by ICP-MS [52]. e MNPs used as carriers for fluorescence assays with organic quencher (Q) and F as probes coupled with MNAzymes for fluorescence detection [51, 53]. f Catalytic NPs of CuMn-CeO2 modified with luminol as probes in an MNAzyme-mediated assay for ECL detection [54]